• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Deep-brain stimulation

Boston Scientific wins CE Mark for Vercise Gevia DBS

June 6, 2017 By Brad Perriello

Boston Scientific (NYSE:BSX) said today that it won CE Mark approval in the European Union for its Vercise Gevia deep-brain stimulation device for treating movement disorder symptoms. Marlborough, Mass.-based Boston Scientific said the new system features programming software called the Vercise Neural Navigator 2 with Stimview, designed to allow physicians to see images of the stimulation field while the […]

Filed Under: Neuromodulation/Neurostimulation, Regulatory/Compliance, Wall Street Beat Tagged With: Boston Scientific, Deep-brain stimulation

FDA clears Medtronic’s StealthStation DBS lead placement software

September 26, 2016 By Brad Perriello

Medtronic (NYSE:MDT) said today that the FDA granted 510(k) clearance for its StealthStation software, which is designed to help plan the placement of the leads used for deep-brain stimulation therapy. Fridley, Minn.-based Medtronic said StealthStation is designed to work with its O-arm imaging system to integrate pre-operative planning and intraoperative imaging during DBS device implantations. “The […]

Filed Under: Food & Drug Administration (FDA), Neuromodulation/Neurostimulation, Regulatory/Compliance Tagged With: Deep-brain stimulation, Medtronic

Medtronic wins CE Mark for SureTune2 DBS software

August 8, 2016 By Brad Perriello

Medtronic (NYSE:MDT) said today that it won CE Mark approval in the European Union for the SureTune2 software used with its deep-brain stimulation devices. The software is designed to allow physicians to fine-tune patients’ therapy “by visualizing patient-specific information in one comprehensive view including anatomy, physiology, and calculated stimulation field,” the Fridley, Minn.-based company said. “Medtronic […]

Filed Under: Neuromodulation/Neurostimulation, Regulatory/Compliance, Software / IT Tagged With: Deep-brain stimulation, Medtronic

Medtronic warns on wire fracture risk with Activa DBS devices

July 5, 2016 By Brad Perriello

Medtronic (NYSE:MDT) last month cautioned surgeons to be careful not to implant its Activa deep-brain stimulation devices with sharply bent or kinked wires, after receiving reports of wire fracture. In a June letter to physicians, Fridley, Minn.-based Medtronic said it learned of 16 instances of high impedance measurements that were later found to be caused […]

Filed Under: Neuromodulation/Neurostimulation, Regulatory/Compliance Tagged With: Deep-brain stimulation, Medtronic

FDA expands approval for Medtronic’s deep-brain stimulation for Parkinson’s

February 17, 2016 By Brad Perriello

Medtronic (NYSE:MDT) said today that it won expanded approval for its deep-brain stimulation therapy for patients with Parkinson’s disease, which 1st won approval from the safety watchdog in 2002. The expanded approval covers patients who have had a Parkinson’s diagnosis for 4 years and recently developed motor complications, or have long-standing motor complications that can’t be […]

Filed Under: Food & Drug Administration (FDA), Neuromodulation/Neurostimulation, Regulatory/Compliance Tagged With: Deep-brain stimulation, Medtronic, Parkinson's disease

St. Jude Medical wins CE Mark for Infinity DBS device

September 22, 2015 By Brad Perriello

St. Jude Medical (NYSE:STJ) said today that it won CE Mark approval in the European Union for its Infinity deep-brain stimulation device and directional lead for treating movement disorders. Little Canada, Minn.-based St. Jude said the Infinity system is designed so that Apple (NSDQ:AAPL) mobile devices can be used as wireless controllers, via a Bluetooth connection. It’s […]

Filed Under: Neuromodulation/Neurostimulation, Regulatory/Compliance Tagged With: CE Mark, Deep-brain stimulation, stjudemedical

Boston Scientific inks DBS deal with Brainlab

April 28, 2015 By Mark Hollmer Leave a Comment

Boston Scientific inks DBS deal with Brainlab

Filed Under: Neuromodulation/Neurostimulation, News Well Tagged With: Boston Scientific, Brainlab, Deep-brain stimulation, Distribution

Medtronic wins EU approval for MRI-safe Activa DBS devices

April 22, 2015 By Brad Perriello Leave a Comment

Medtronic wins EU approval for MRI-safe Activa DBS devices

Medtronic (NYSE:MDT) said today that it won European approval for full-body MRI scans of patients implanted with its Activa deep-brain stimulation device.

Filed Under: News Well, Regulatory/Compliance Tagged With: CE Mark, Deep-brain stimulation

Boston Scientific wins CE Mark for Vercise brain stim device

September 17, 2014 By Brad Perriello Leave a Comment

Boston Scientific wins CE Mark for Vercise brain stim device

Filed Under: News Well, Regulatory/Compliance Tagged With: Boston Scientific, CE Mark, Deep-brain stimulation, Parkinson's disease

Medtronic drops $200M on Dutch DBS firm Sapiens

August 26, 2014 By Brad Perriello Leave a Comment

Medtronic drops $200M on Dutch DBS firm Sapiens

Filed Under: Mergers & Acquisitions, News Well, Wall Street Beat Tagged With: Deep-brain stimulation, Sapiens Brain Steering Stimulation GmbH

UPDATE: Boston Scientific touts Vercise DBS for Parkinson’s

June 12, 2014 By Brad Perriello Leave a Comment

Boston Scientific touts Vercise DBS for Parkinson's

UPDATED June 12, 2014, with results from an additional trial.

Boston Scientific (NYSE:BSX) this week touted positive data from a pair of clinical studies using its Vercise deep-brain stimulation device to treat Parkinson’s disease.

Filed Under: News Well Tagged With: Boston Scientific, Clinical Trials, Deep-brain stimulation, Parkinson's disease

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS